Automated Visual Field Analyzer Market is Segmented By Product Type (Static, Kinetic), By Application(Glaucoma, Age-related macular degeneration (AMD), Scotoma, Others), By End-User(Hospital, Ophthalmic Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview
Automated Visual Field Analyzer Market is expected to reach at a CAGR of 6.0% during the forecast period (2024-2031).
The automated visual field analyzer provides several advantages over the manual visual field analyzer, including the ability to rapidly deliver more sensitive and accurate findings and govern the recording of patient responses, resulting in more dependable results. This type of perimetry is the most commonly used in clinical practice and research trials where the loss of visual field is measured.
Market Summary
| Metrics | Details |
| Market CAGR | 6% |
| Segments Covered | By Product Type, By Application, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To Get a Free Sample Click here
Market Dynamics
Technological advancements in automated visual field analyzers are expected to drive market growth.
Computerized automated perimetry is a standardized and efficient method to evaluate a patient’s visual field sensitivity. For instance, The Humphrey Field Analyzer (Carl Zeiss Meditec, Inc) incorporates the Swedish Interactive Threshold Algorithm (SITA) strategy. Currently, the SITA Standard is the conventional threshold estimation procedure in most clinical settings. Moreover, Advanced Vision Analyser (Elisar Vision Technology), a new portable, lightweight virtual reality headset perimeter with optics that allows visual field analysis under test conditions that are compatible with standard automated perimetry with eye-tracking and a cloud-based storage system that allows data backup. An Elisar Standard Algorithm has been adapted for the AVA (ESA). Additionally, Head-mounted perimetry devices have been described with the benefit of being especially useful in patients with physical disabilities. Thus, the market is expected to drive in the forecast period from the above statements.
Restraint:
The expensive cost of an automated visual field analyzer, a scarcity of ophthalmologists, and rising competition and price pressure among major providers are some factors that the market is expected to get hampered in the forecast period.
COVID-19 Impact Analysis on Market
The pandemic caused by the SARS-CoV-2 virus led to a near-worldwide lockdown, had a disastrous impact on daily ophthalmology services. Ophthalmologists are at high risk due to their closeness and the short working distance at the time of slit-lamp examination. Eye care professionals can be caught unaware because conjunctivitis may be one of the first signs of COVID-19 at presentation, even precluding the emergence of additional symptoms such as dry cough and anosmia. Moreover, adults or children with sudden-onset painful or painless visual loss, sudden-onset squint, sudden-onset floaters or severe lid edema are taken to urgent care. Retinal screening is unnecessary for coronavirus patients taking chloroquine or hydroxychloroquine as the probability of toxic damage to the retina is less due to the short duration of drug therapy.
Additionally, it has clinically impacted reducing the number of appointments, avoiding specific treatment options, applying extra tools and implementing new techniques. Tele-ophthalmology and artificial intelligence are preferred for increasing doctor-patient interaction. Furthermore, the consistent virus spread has significantly obstructed the supply chain of the key automated visual field analyzer market. Thus, the market will undergo impetus during the forecast period.
Market Segmentation Analysis
The glaucoma segment is expected to hold the largest market share in the automated visual field analyzer market.
The glaucoma segment accounted for the largest market share in 2020. According to the Centers for Disease Control and Prevention in 2020, glaucoma is a group of disorders that affect the eye's optic nerve and result in vision loss and blindness. Glaucoma is caused by a gradual increase in the normal fluid pressure inside the eyes. Glaucoma can, however, develop with normal eye pressure, according to a recent study. The disease is known as a "sneak thief of sight" because it is a chronic disorder that grows slowly over time without the sufferer detecting vision loss until the disease is severe.
In contrast, Angle-closure can occur rapidly and is unpleasant. However, vision loss can happen swiftly; the agony and discomfort prompt individuals to seek medical help before severe damage occurs. Glaucoma affects more than 3 million Americans, with open-angle glaucoma affecting 2.7 million of those aged 40 and older. Thus, the above statements show an increase in the demand for an automated visual field analyzer which is expected to hold the largest market share in the forecast period.
Automated Visual Field Analyzer Market
The static segment is expected to hold the largest market share in the automated visual field analyzer market.
The static segment accounted for the largest market share in 2020. The static perimeter is the preferred method for measuring visual field quality, identifying glaucoma, and monitoring glaucoma-related changes in the visual field. Static perimetry tests different locations throughout the field one at a time. Threshold static perimetry is generally done using automated equipment. It is used for rapid screening and follow-up of diseases involving deficits such as scotomas, loss of peripheral vision and more subtle vision loss. Perimetry testing is important in the screening, diagnosing, and monitoring of various eye, retinal, optic nerve and brain disorders. Thus, the market is expected to hold the largest market share in the forecast period from the above statements.
Market Geographical Share
North America region holds the largest market share in the global automated visual field analyzer market
In 2020, North America accounted for the highest revenue share. The increasing prevalence of ophthalmic diseases, the high adoption of the latest technologies, favorable reimbursement policies, product launches by the market players are some factors the market is expected to boost in the forecast period. For instance, according to the American Association for Pediatric Ophthalmology and Strabismus reports, cataract is still the primary cause of blindness and visual loss worldwide. Visual impairment reduces a person's ability to do daily tasks, work, and care for dependents, all of which negatively influence their quality of life. Reduced vision can also raise the risk of fall-related injuries and fractures, leading to hospitalization in 20% of cases. Depending on the cataract severity, these negative consequences will vary from patient to patient. A cataract affects around three out of every 10,000 children. Moreover, estimates for cataract demand in Ontario, Canada, ranging from 72 % to 144 % over the next 25 years, while publically-funded outpatient operational capacity will rise at a much slower pace. Therefore, there will be an increase in the demand for automated visual field analyzers.
Market Companies and Competitive Landscape
Major key players in the automated visual field analyzer market are Carl Zeis, Haag-Streit AG, Elektron Eye Technology, Heidelberg Engineering, Kowa Company, Ltd., OPTOPOL USA, OCULUS, Inc., Metrovision, MEDA Co., Ltd. and Topcon Corporation.
OPTOPOL USA:
Overview:
OPTOPOL USA is a U.S. subsidiary of Optopol Technologies, one of the leading providers of innovative ophthalmic diagnostic equipment such as the Optopol PTS perimeter and the Optopol REVO 130 OCT. Since 2001, Optopol Technologies developed and released some of the most innovative products, such as the first spectral-domain OCT in the world. They continue this innovation with the world's fastest OCT and most capable line of perimeters. The company devices provide diagnostics for Ophthalmic Disease processes such as Glaucoma visual field loss.
Product Portfolio:
PTS 2000: The PTS 2000 is an Automated Projection Perimeter with the latest visual field testing standards. Utilizing the most advanced testing techniques available, the PTS 2000 provides fast testing strategies, customizable patterns, kinetic testing and all Goldmann stimuli sizes.
